Genelux (GNLX) Share-based Compensation (2022 - 2026)
Genelux (GNLX) reported Share-based Compensation of $1.39 million for Q1 2026, down 2.0% from $1.42 million a year earlier and down 9.2% from the prior quarter.
Powered by 
Analysis
Genelux (GNLX) Share-based Compensation (2022 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, Genelux's Share-based Compensation came in at $5.84 million, up 3.0% year-over-year; for FY2025, it came in at $5.87 million, up 2.3% from FY2024.
- Share-based Compensation has increased for three consecutive years, with a three-year compound annual growth rate of 34.5% (FY2022 to FY2025).
- By year, Share-based Compensation came in at $5.74 million in FY2024 (+128.2%), $2.52 million in FY2023 (+4.1%) and $2.42 million in FY2022.
- Five-year quarterly Share-based Compensation spans a low of $43,000 in Q4 2022 and a high of $1.62 million in Q3 2025.
- Year over year, Share-based Compensation gained in four of the last eight quarters, with growth averaging 79.6%.
- The high point for year-over-year Share-based Compensation in five years was Q1 2024 (growth of 555.9%); the low point was Q1 2023 (a decline of 39.0%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $1.54 million (Q4 2025), $1.62 million (Q3 2025) and $1.29 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Genelux | 91.17 Mn | 29.45 Mn | - | 1.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.78 Mn |
| Dec 31, 2025 | 1.92 Mn |
| Sep 30, 2025 | 2.64 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.53 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Dec 31, 2023 | 1.53 Mn |
| Sep 30, 2023 | 515,000.00 |
| Jun 30, 2023 | 240,000.00 |
| Mar 31, 2023 | 227,000.00 |
| Dec 31, 2022 | 43,000.00 |
| Mar 31, 2022 | 372,000.00 |
API Access
Genelux Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GNLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "GNLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GNLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();